baber/WOPTO huggingface dataset:
Patent DE-69626530-T2 (DE)
Inventor: SIGBJORNSEN SIGURD
IPC: G09C5/00
Filed: 1996-07-10
Granted: 2003-11-13
Abstract: An arrangement to protect software, particularly freely distributed application software, against utilization without permission of the copyright holder. By encrypting the software employing a key (k1) which is different from that key (k2) which is employed in the decryption, better protection is obtained against unauthorized utilization when the decryption key is kept secret to the user. Further improved security is achieved by additionally executing scrambling-descrambling of the communication between the computer in which the software is utilized and the external unit in which the decryption key is stored. Also, the external unit is arranged such that it returns to the host computer, the result from its processing of data received from the host, the result then being utilized in the further execution of the respective program. <IMAGE>
Patent DE-69634801-T2 (DE)
Inventor: KUMMER A
IPC: A61G7/018
Filed: 1996-07-25
Granted: 2005-10-27
Abstract: A bed includes a base frame, a deck coupled to the base frame for supporting a body, a peer-to-peer communication network having a plurality of connection points, and a plurality of modules. Each module is electrically coupled to a selected connection point of the peer-to-peer communication network. Each module is configured to perform a dedicated function during operation of the bed, and each module is configured to communicate over the peer-to-peer communication network with selected other modules.
Patent DE-69635479-T2 (DE)
Inventor: BRENDZEL M
IPC: A61F2/24
Filed: 1996-06-07
Granted: 2006-06-08
Abstract: A heart valve prosthesis having a valve housing providing a lumen therethrough. The valve housing has a first annulus on one end and a second annulus on the other end spaced apart from the first annulus. A suture cuff is used for attaching the valve housing to heart tissue of a patient. The cuff is attached between the first annulus and the second annulus. The cuff is positioned such that prosthesis is attached in a supra-annular position relative to a tissue annulus of the heart. The design allows for an increased valve lumen.
Patent DE-69700006-T2 (DE)
Inventor: MAURIN VERONIQUE
IPC: A61K8/34
Filed: 1997-02-03
Granted: 1998-08-20
Abstract: Pressurised vessel equipped with a distributor head and containing a transparent monophase composition comprising (A) 0.5-10 wt. % of a propellant gas and (B) 90-99.5 wt. % of an aqueous composition comprising a mixture of surfactants selected from nonionic and amphoteric surfactants, wherein the vessel delivers a foam when the distributor head is activated.
Patent DE-69707964-T2 (DE)
Inventor: MOESGAARD SVEN
IPC: A61K33/04
Filed: 1997-04-30
Granted: 2002-08-29
Abstract: Antioxidative pharmaceutical formulation comprising L-selenomethionine,  beta -carotene, ascorbic acid (vitamin C), D- alpha -tocopherylacetate (vitamin E) and L-methionine together with a pharmaceutically acceptable carrier therefor.
Patent DE-69712626-T2 (DE)
Inventor: HALAZY SERGE
IPC: A61P25/04
Filed: 1997-06-12
Granted: 2002-11-28
Abstract: PCT No. PCT/FR97/01053 Sec. 371 Date Dec. 16, 1998 Sec. 102(e) Date Dec. 16, 1998 PCT Filed Jun. 12, 1997 PCT Pub. No. WO97/48680 PCT Pub. Date Dec. 24, 1997The invention discloses the methanesulphonate salt of 4-(4-{2-[3-(2-amino-ethyl)-1H-indol-5-yloxy]-acetyl}-piperazin-1-yl)-benzonitrile, its solvates or hydrates as well as the preparation of the said salt. The invention also discloses the pharmaceutical compositions containing the said salt, useful in the preparation of medicines for treating vasospastic disorders.
Patent DE-69712754-T2 (DE)
Inventor: NAGY JON O
IPC: A61K47/44
Filed: 1997-02-28
Granted: 2002-10-17
Abstract: This invention provides compositions for inhibiting the binding between two cells, one expressing P- or L-selectin on the surface and the other expressing the corresponding ligand. A covalently crosslinked lipid composition is prepared having saccharides and acidic group on separate lipids. The composition is then interposed between the cells so as to inhibit binding. Inhibition can be achieved at an effective oligosaccharide concentration as low as 106 fold below that of the free saccharide. Since selectins are involved in recruiting cells to sites of injury, these composition scan be used to palliate certain inflammatory and immunological conditions.
Patent DE-69718867-T2 (DE)
Inventor: VAN DEN ENDEN JOSEPH
IPC: H03L7/06
Filed: 1997-04-08
Granted: 2003-11-13
Abstract: An apparatus for reproducing a digital information signal from a record carrier includes a read unit for reading a signal from a track on the record carrier, a bit detection unit for deriving the digital information signal from the signal read from the track in response to a clock signal and a phase locked loop for deriving the clock signal from the signal read from the track. The phase locked loop includes a phase comparator for deriving a phase error signal and a voltage controlled oscillator for deriving the clock signal. The apparatus further includes a sync pattern detector for detecting sync patterns occurring in the digital information signal and a counter for counting the number of bits occurring between two sync patterns in the digital information signal. If the number of bits counted between the two sync patterns exceeds a predetermined value (THR) by at least one, at least one additional bit is inserted into the digital information signal (an insertion error) and this at least one additional bit should be deleted from the digital information in order to keep the apparatus in synchronisation. When the predetermined number exceeds the number of bits counted by at least one, at least one bit was deleted from the digital information signal (a deletion error), so that at least one bit should be added in order to keep the apparatus in synchronization.
Patent DE-69723834-T2 (DE)
Inventor: WIRT DAVID F
IPC: A61L2/18
Filed: 1997-05-20
Granted: 2004-04-15
Abstract: A dispenser for dispensing products such as liquid antimicrobials is described. The dispenser includes a bracket/actuator assembly (34) and a container assembly (32). The dispenser includes a novel mechanism for attaching the container assembly (32) to the bracket/actuator assembly (34) and also includes a novel valve assembly (40). <IMAGE>
Patent DE-69735739-T2 (DE)
Inventor: CHOW CALVIN Y H
IPC: G01N27/447
Filed: 1997-07-03
Granted: 2007-05-10
Abstract: In a microfluidic system (partially shown by element 178 in the figure and elements thereupon) using electrokinetic forces, the present invention uses electrical current or electrical parameters, other than voltage, to control the movement of fluids through the channels of the system. Time-multiplexed power supplies (200 and 202) also provide further control over fluid movement by varying the voltage on an electrode connected to a fluid reservoir of the microfluidic system, by varying the duty cycle during which the voltage is applied to the electrode, or by a combination of both. A time-multiplexed power supply can also be connected to more than one electrode for a saving in cost. <IMAGE>
Patent DE-69805118-T2 (DE)
Inventor: BAENA RICHARD
IPC: F16L55/053
Filed: 1998-01-28
Granted: 2002-11-21
Abstract: The pressure chamber comprises a rigid shell (2) with apertures (7,8) at opposite ends, and an elastically-deformable separator (6) inside the shell dividing its inner volume (3) into two compartments (4,5) of variable volume. The first compartment is filled with solid, elastically-deformable elements (14), in the shape of hollow cylinders of silicone measuring 2.5-4mm in diameter by 3-8mm long, the total volume of which is equivalent to the volume of the first compartment when at rest. The first compartment also contains a liquid lubricant, e.g. glycol, glycerine, silicone oil or mineral oil, whilst the second compartment (5) is connected via its aperture (8) to the hydraulic fluid circuit.
Patent DE-69809246-T2 (DE)
Inventor: RUHLMANN ERIC
IPC: A61K45/06
Filed: 1998-08-03
Granted: 2003-08-28
Abstract: The invention concerns a product comprising at least a double stranded RNA combined with at least a 6-benzyluracil derivative to be used in therapy simultaneously, separately or spread over time. Said product can be optionally combined with another antiviral agent. Said products are particularly useful for treating AIDS (Acquired Immuno Deficiency Syndrome).
Patent DE-69812925-T2 (DE)
Inventor: SARANGAPANI SHANTHA
IPC: C08L101/00
Filed: 1998-05-04
Granted: 2004-01-29
Abstract: Disclosed are coatings and materials that resist bacterial colonization and encrustation for use in medical devices and urological applications. The coating includes acidic chelating components, reactively bound to a hydrophilic polyurethane prepolymer along with noble metal combinations or antibacterials. The acidic and noble metal combinations can also be incorporated as additives during plastic molding of medical devices. A continuous antibacterial surfaces are provided by such coatings and materials.
Patent DE-69822861-T2 (DE)
Inventor: DODGE ALAN
IPC: A61P43/00
Filed: 1998-09-18
Granted: 2005-01-27
Abstract: This invention provides novel benzothiophene compounds of formula I:which are useful for the inhibition of the various medical conditions associated with postmenopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus, and cervix. The present invention further. relates to pharmaceutical formulations of compounds of formula I.
Patent DE-69824023-T2 (DE)
Inventor: SCHLOM JEFFREY
IPC: A61P43/00
Filed: 1998-09-22
Granted: 2005-05-12
Abstract: The present invention relates to the preparation and use of peptides that act as agonists and antagonists of human carcinoembryonic antigen (CEA). Agonists of the CEA peptide, CAP1, are disclosed and their utility in enhancing immune responses against CEA demonstrated.
Patent DE-69825766-T2 (DE)
Inventor: RIGGS LYNN
IPC: A01N47/34
Filed: 1998-09-01
Granted: 2005-08-25
Abstract: A method for combatting plant fungi in a plant, which comprises applying to the seeds or tubers of the plant, an effective amount of a fungicidal composition comprising a fungicidally effective amount of a 2-alkoxyiminoacetamide compound, optionally in admixture with one or both of an alkylene bis-dithiocarbamate complex salt and a thiophanate compound. Fungicidal compositions comprising a fungicidally effective amount of a 2-alkoxyiminoacetamide compound, an alkylene bis-dithiocarbamate complex salt, and a thiophanate compound, are also described.
Patent DE-69826457-T2 (DE)
Inventor: RYAN M
IPC: D04H1/42
Filed: 1998-05-04
Granted: 2005-10-13
Abstract: The present invention relates to a fibrous material which includes a plurality of polylactide containing fibers. The plurality of polylactide containing fibers can be considered low shrinkage or high shrinkage. The plurality of polylactide containing fibers are considered low shrinkage fibers if they provide a boiling water shrinkage propensity of less than about 20%. The plurality of polylactide containing fibers are considered high shrink fibers if they provide an average fiber boiling water shrinkage propensity of greater than about 10% and a heat of fusion of less than about 25 J/g. The invention additionally relates to the use of an extrusion process to provide low shrinkage fibers and high shrinkage fibers. The invention further relates to the use of these fibers in desirable products.
Patent DE-69830937-T2 (DE)
Inventor: BEGHELLI GIAN PIETRO
IPC: G08B5/36
Filed: 1998-03-03
Granted: 2006-05-24
Abstract: An emergency lighting fixture (10, 115) especially for industrial environments, generally comprising a central body (20), at least one source of light constituted by an incandescent halogen lamp (11, 12) held inside a parabolic reflector (13, 14) and a transparent shell (15) covering the fixture's (10, 11) central body (20). The reflector (13, 14) is adjustable by the operator from the outside, after lifting the transparent shell (15), so as to regulate the direction of the light beam. Each reflector (13, 14) is associated with a container (131, 141) for a laser light source (17, 17A), capable of providing an emergency lighting system, for instance in the presence of smoke in the surrounding environment. A regulating device (465) of the laser light beam (105) includes a ring nut (125) swiveling in a horizontal plane and a plate (135) for vertical adjustments, so as to make it possible to position the laser beam (105) within pre-established angles. <IMAGE>
Patent DE-69830995-T2 (DE)
Inventor: CARSON A
IPC: C07D487/04
Filed: 1998-05-18
Granted: 2006-04-20
Abstract: Novel, heterocyclic compounds having at least one ring nitrogen, disclosed side chains and, in some embodiments, an oxygen ortho to the ring nitrogen inhibit inflammatory responses associated with TNF-alpha and fibroblast proliferation in vivo and in vitro. The compounds of the invention neither appreciably inhibit the activity of cAMP phosphodiesterase nor the hydrolysis of phosphatidic acid, and are neither cytotoxic nor cytostatic. Preferred compounds of the invention are esters. Methods for the use of the novel compounds to inhibit ceramide-mediated intracellular responses in stimuli in vivo (particularly TN-alpha) are also described. The methods are expected to be of use in reducing inflammatory responses (for example, after angioplasty), in limiting fibrosis (for example, of the liver in cirrhosis), in inhibiting cell senescence, cell apoptosis and UV induced cutaneous immune suppression. Compounds having enhanced water solubility are also described.
Patent DE-69832128-T2 (DE)
Inventor: KOSHIYAMA KOJI
IPC: H02G15/08
Filed: 1998-06-02
Granted: 2006-07-27
Abstract: A closure for a cable connection capable of facilitating access to fiber connection sections, ensuring simplified management, assembling and disassembling, and exhibiting increased sealing and resealing characteristics. A base member (2) is formed at a portion of an outer surface thereof positioned around each of cable insertion holes (1) with a cylindrical pocket (10), in which a cable bush (13) made of a rubber-like elastic material and formed with a through-hole (12) communicating with a respective one of the cable insertion holes (1) is fittedly arranged. A cable seal cap (14) which has a raised surface (141) for abutting against the cable bush (13) is releasably fitted in the cylindrical pocket (10) to bring the cable bush (13) into elastic contact with a cable (C). <IMAGE>
Patent DE-69838400-T2 (DE)
Inventor: STERNBY JAN
IPC: A61M/
Filed: 1998-12-02
Granted: 2009-01-22
Abstract: The mass of urea in a fluid volume is calculated by performing mass exchange between the fluid volume and an exchange fluid flow. The concentration of the urea is repeatedly measured in the exchange fluid flow after the mass exchange to obtain a concentration curve. An approximation curve is fitted to at least a portion of the concentration curve. The logarithm of the approximation curve is a straight line whose slope is used to calculate the urea concentration.
Patent DE-69905732-T2 (DE)
Inventor: LECLERC PASCAL
IPC: B65D51/16
Filed: 1999-09-07
Granted: 2003-12-18
Abstract: The invention concerns a device for sealing a bottle containing a sparkling wine and includes a stopper, particularly made of cork or a synthetic material, capable of being inserted in the neck of the bottle, maintained thereon by a wire cap, and run through in the axial direction, by a conduit having first and second ends capable of communicating respectively with the bottle's internal volume and external volume. The second end is closed by a retractable closer. The device is characterized in that the stopper is axially run through by an orifice designed to receive the conduit and having an adjusted and tight cross-section relative to the conduit external section, the latter being provided at its second end, with a support flange capable of resting against the stopper upper surface.
Patent DE-69915061-T2 (DE)
Inventor: JOUVE ISABELLE
IPC: C07C51/377
Filed: 1999-06-16
Granted: 2005-02-03
Abstract: The invention concerns a method for preparing p-hydroxymandelic compounds optionally substituted and their derivatives. More particularly, it concerns a method for preparing p-hydroxymandelic acid and methoxy-3 p-hydroxymandelic acid and their derivatives. The invention concerns a method for preparing p-hydroxymandelic compounds optionally substituted and their derivatives, which consists in condensing in water, in the presence of an alkaline agent, an aromatic compound bearing at least a hydroxyl group and whereof the position in para is free, with glyoxylic acid, said method being characterised in that the reaction is carried out in the presence of an efficient amount of a compound bearing at least two carboxylic functions.
Patent DE-69917248-T2 (DE)
Inventor: MARGOLIN SOLOMON B
IPC: A61K31/4436
Filed: 1999-03-01
Granted: 2005-05-04
Abstract: In a preferred embodiment, a method of treating bacteria, fungi, and/or viruses on the surface of, or within, the layers of the dermis of skin, ears, fingernails, toenails, or hoofs of mammalian species, comprising: applying to the surface or layers a pharmaceutical substance including an effective amount of one or more 2-(1H) pyridone compound(s).
Patent DE-69919307-T2 (DE)
Inventor: KASHIWAZAKI KAZUHISA
IPC: C22F1/00
Filed: 1999-05-17
Granted: 2005-03-24
Abstract: An aluminum sheet material for automobiles is herein disclosed, having an aluminum alloy composition: (i) comprising 3.5 to 5 wt% of Si, 0.3 to 1.5 wt% of Mg, 0.4 to 1.5 wt% of Zn, 0.4 to 1.5 wt% of Cu, 0.4 to 1.5 wt% of Fe, and 0.6 to 1 wt% of Mn, and one or more members selected from the group of 0.01 to 0.2 wt% of Cr, 0.01 to 0.2 wt% of Ti, 0.01 to 0.2 wt% of Zr, and 0.01 to 0.2 wt% of V, with the balance of aluminum and unavoidable impurities, or (ii) comprising between more than 2.6 wt% and 5 wt% of Si, 0.2 to 1.0 wt% of Mg, 0.2 to 1.5 wt% of Zn, 0.2 to 1.5 wt% of Cu, 0.2 to 1.5 wt% of Fe, and between 0.05 and less than 0.6 wt% of Mn, and one or more members selected from the group of 0.01 to 0.2 wt% of Cr, 0.01 to 0.2 wt% of Ti, 0.01 to 0.2 wt% of Zr, and 0.01 to 0.2 wt% of V, with the balance of aluminum and unavoidable impurities. It is possible to produce an aluminum sheet material for automobiles that has excellent mechanical strength and bending property as well as enhanced weldability, by making the recycling use of recycled aluminum materials.
Patent DE-69919883-T2 (DE)
Inventor: GAULT PHILIPPE
IPC: A61K6/00
Filed: 1999-10-12
Granted: 2005-09-15
Abstract: The present invention concerns a method of manufacturing a dental implant comprising: preparing an implant composed of a root portion and a crown portion and constituted by an inert biocompatible material in a shape which is adapted to an extracted tooth; immersing the root portion of said implant into a culture of undifferentiated mesenchymal cells in a culture medium the composition of which allows differentiation into cementoblasts and fibroblasts, over a period which is sufficient for said differentiation and for adhesion of cementoblasts to the root portion and the formation of a first layer of cementum and an alveolodental ligament primordium attached to said cementum; recovering the implant carrying differentiated tissues affixed to its root portion.
Patent DE-69921409-T2 (DE)
Inventor: SINGH AMARJIT
IPC: A61K9/48
Filed: 1999-08-16
Granted: 2006-03-09
Abstract: The invention disclosed a homogenous substantially alcohol free composition of Cyclosporin which comprises a Cyclosporin in a hydrophilic carrier medium comprising propylene glycol, esters of propylene glycol with C4 to C12 fatty acids and polyoxyethylene hydrogenated castor oils wherein the ingredients are present in the following ranges, Cyclosporin 1 - 25% w/w, Propylene Glycol 5 - 50% w/w, Esters of Propylene Glycol with C4 to C12 fatty acids 10 - 40% w/w and Polyoxyethylene hydrogenated Castor oils 25 - 60% w/w.
Patent DE-69926917-T2 (DE)
Inventor: YU LONG
IPC: B29C48/03
Filed: 1999-12-13
Granted: 2006-06-08
Abstract: A biodegradable polymer is disclosed having the composition g) from 8 to 80 % by weight of a starch modified to include an hydroxyalkyl C2-6 group or modified by reaction with an anhydride of a dicarboxylic acid, preferably hydroxypropylated high amylose starch, a) from 0 to 87.9 % of starch, b) from 4 to 11 % by weight of a water soluble polymer selected from polyvinylacetate, polyvinyl alcohol and copolymers of ehtylene and vinylalcohol which have a melting point compatible with the molten state of the starch components, c) from 0 to 20 % by weight of a polyol plasticiser, preferably glycerol, d) from 0.1 to 1.5 % by weight of a C12-22 fatty acid or salt, preferably stearic acid and, e) 0 to 12 % added water. The polymers are suitable as biodegradable rigid sheet or flexible film materials for use in packaging foodstuffs.
Patent TR-200001600-T2 (TR)
Title: Aril -8-oksodihidropurin türevleri, üretim prosesleri, bunları içeren farmasötik terkipler, ve ara ürünleri.
Inventor: MURATA TERUYA
IPC: A61P25/26
Filed: 1998-11-26
Abstract: Genel formül (1) ile temsil edilen 2-aril-8-oksodihidropürin türevleri ve farmasötik olarak kabul edilir asit katki tuzlari. Bu bilesimler, anksiyete ile ilgili hastaliklar (nevroz, psiko-fizyolojik bozukluklar, anksiyete hastaliklari vs), depresyon ve epilepsi gibi merkezi sinir sistemi hastaliklari ve anjin pektoris ve yüksek tansiyon gibi dolasim hastaliklari için tedavi ve önlemede kullanilir. Bahsi geçen formülde;a, tercihe göre ikameli fenil veya heteroaril olup, X veya y ise [Q] :-CH(R3)CON(R1)(R2)'dir.
Patent TR-200100063-T2 (TR)
Title: Androst-5-en-3ß,17ß-diol için farmasötik kompozisyonlar ve kullanımlar
Inventor: LABRIE FERNAND
IPC: A61P15/00
Filed: 1999-06-10
Abstract: Androst-5-en-3 , 17 -diol; osteoporoz veya menopoz semptomlari veya östrojen reseptör aktivitesinden etkilenen diger hastaliklari tedavi etmek veya bunlara yakalanma olasiligini azaltmak için ve DHEA tedavisine iyi yanit veren, ancak, daha androjenige karsi östrojenik etkilerin daha yüksek bir oraninin istendigi durumlar için kullanilmaktadir. Talep edilen metotlar ve kombinasyonlarin aktif muhteviyatlarini saglamak için, kitler ve farmasötik kompozisyonlar oldugundan, kombinasyon terapileri dahil edilmektedir. (Sekil 1)
Patent TR-200100389-T2 (TR)
Title: Glomerulpatinin tedavisi veya önlenmesi için terkip.
Inventor: KURIHARA HIDETAKE
IPC: A61K31/404
Filed: 1998-07-17
Abstract: Bu bulus, özellikle glomerulonefrit ve diyabetik nöropati olmak üzere glomerulopatinin tedavisi ve önlenmesi için, bir üstün antiproteinürik etkiye sahip olan bir terkip ve tip IV kollajenaz için bir üstün inhibisyon faaliyetine sahip bir yeni bilesik ile tedavi ya da önlemek bir antiproteiürik etki ve onu içeren bir terkip ile ilgilidir.
Patent TR-200100885-T2 (TR)
Inventor: FERGUSON THOMAS HARRY
IPC: A61K31/00
Filed: 1999-03-24
Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
Patent TR-200102160-T2 (TR)
Title: Çoklu ses aksesuarlarına mahsus taşınabilir bir telekomünikasyon cihazı.
Inventor: RUBBMARK JAN RAGNAR
IPC: H04M1/72412
Filed: 2000-01-17
Abstract: Tasinabilir bir telekominikasyon cihazi (1) olup, cihaz, sesin alinmasina mahsus ses giris vasitasina (8), sesin hasil edilmesine mahsus ses çikis vasitasina (9), ses giris vasitasini ve ses çikis vasitasini kontrol etmeye mahsus bir kontrol düzenine, ve harici sesi alma ve ses sinyalleri olarak bunu cihaza sevk etme yeterliligindeki ve/veya cihazdan ikmal edilen ses sinyallerine cevaben harici sesi hasil etme yeterliligindeki bir harici ses aksesuarini (10, 20) çalisabilir olarak baglamaya mahsus bir ses aksesuari ara yüzüne (6, 7) sahip bulunmaktadir.